A dynamic COVID-19 immune signature includes associations with poor prognosis

Laing, Adam G., Lorenc, Anna, del Molino del Barrio, Irene, Das, Abhishek, Fish, Matthew, Monin, Leticia, Muñoz-Ruiz, Miguel, McKenzie, Duncan R. +42 more·2020·Nature Medicine

Cited by (953)

Items 201–300 of 953

  1. The impact of DAMP-mediated inflammation in severe COVID-19 and related disorders
    Upasana Parthasarathy, Roberta Martinelli, Elisabeth H. Vollmann, Katharine Best, Alex G. Therien · 2021 · Biochemical Pharmacology
  2. Differential Cytokine Signatures of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Influenza Infection Highlight Key Differences in Pathobiology
    Andrew H. Karaba, Weiqiang Zhou, Leon L. Hsieh, Alexis Figueroa, Guido Massaccesi, Richard Eric Rothman, Katherine Z J Fenstermacher, Lauren M Sauer, Kathryn Shaw‐Saliba, Paul W. Blair et al. · 2021 · Clinical Infectious Diseases
  3. Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity
    Federica Maria Bozzano, Chiara Dentone, Carola Perrone, Antonio Di Biagio, Daniela Fenoglio, Alessia Parodi, Małgorzata Mikulska, Bianca Marisa Bruzzone, Daniele Roberto Giacobbe, Antonio Vena et al. · 2021 · PLoS Pathogens
  4. An update review of globally reported SARS-CoV-2 vaccines in preclinical and clinical stages
    Hamid Motamedi, Marzie Mahdizade Ari, Shirin Dashtbin, Matin Fathollahi, Hadi Hossainpour, Amirhooshang Alvandi, Jale Moradi, Ramin Abiri · 2021 · International Immunopharmacology
  5. BCG Vaccine Derived Peptides Induce SARS-CoV-2 T Cell Cross-Reactivity
    Peter J. Eggenhuizen, Boaz H. Ng, Janet Chang, Ashleigh L. Fell, Rachel M. Y. Cheong, Wey Y. Wong, Poh‐Yi Gan, Stephen Roger Holdsworth, Joshua Daniel Ooi · 2021 · Frontiers in Immunology
  6. Longitudinal Metabolomics Reveals Ornithine Cycle Dysregulation Correlates With Inflammation and Coagulation in COVID-19 Severe Patients
    Tao Li, Nianzhi Ning, Bo Li, Deyan Luo, Enqiang Qin, Wenjing Yu, Jianxin Wang, Guang Yang, Nan Nan, Zhili He et al. · 2021 · Frontiers in Microbiology
  7. Cytokine and Chemokine Levels in Coronavirus Disease 2019 Convalescent Plasma
    Tania S. Bonny, Eshan U. Patel, Xianming Zhu, Evan M. Bloch, M Kate Grabowski, Alison G. Abraham, Kirsten E. Littlefield, Ruchee Shrestha, Sarah E. Benner, Oliver B Laeyendecker et al. · 2020 · Open Forum Infectious Diseases
  8. COVID-19: captures iron and generates reactive oxygen species to damage the human immune system
    Liu Wenzhong, Li hualan · 2021 · Autoimmunity
  9. Integrated miRNA/Cytokine/Chemokine Profiling Reveals Severity-Associated Step Changes and Principal Correlates of Fatality in COVID-19
    Julie C. Wilson, David Kealy, Sally R. James, Tobias Plowman, Katherine Newling, Christopher P. Jagger, Kara J. Filbey, Elizabeth R. Mann, Joanne Elizabeth Konkel, Madhvi Menon et al. · 2021 · iScience
  10. Bone Marrow-Derived Mesenchymal Stromal Cell Therapy in Severe COVID-19: Preliminary Results of a Phase I/II Clinical Trial
    Céline Grégoire, Nathalie Layios, Bernard C. Lambermont, Chantal Lechanteur, Alexandra Briquet, Virginie Bettonville, Étienne Baudoux, Marie Thys, Nadia Dardenne, Benoît Misset et al. · 2022 · Frontiers in Immunology
  11. Ontogeny and Function of Plasmacytoid Dendritic Cells
    Nicholas M. Adams, Annesa Das, Tae Jin Yun, Boris Reizis · 2024 · Annual Review of Immunology
  12. Quantitative assessment of SARS‐CoV‐2 RNAemia and outcome in patients with coronavirus disease 2019
    Kefu Tang, Lei Wu, Ying Luo, Bo Gong · 2021 · Journal of Medical Virology
  13. Profile of Circulatory Cytokines and Chemokines in Human Coronaviruses: A Systematic Review and Meta-Analysis
    Ayat Zawawi, Abdallah Y. Naser, Hassan H Alwafi, Faisal Minshawi · 2021 · Frontiers in Immunology
  14. Interfering with SARS-CoV-2: are interferons friends or foes in COVID-19?
    Ivan Zanoni · 2021 · Current Opinion in Virology
  15. Impaired Humoral Immunity Is Associated With Prolonged COVID-19 Despite Robust CD8 T-Cell Responses
    Olga Lyudovyk, Justin Y. Kim, David Augustus Qualls, Madeline A. Hwee, Ya-Hui Lin, Sawsan R. Boutemine, Yuval Elhanati, Alexander Solovyov, Melanie Douglas, Eunise Chen et al. · 2022 · Cancer Cell
  16. Innate immune cell activation causes lung fibrosis in a humanized model of long COVID
    Lu Cui, Zhuoqing Fang, Cristabelle De Souza, Tristan Lerbs, Yuan Guan, Irene Li, Vivek Charu, Shih-Yu Chen, Irving L. Weissman, Gerlinde Wernig · 2023 · Proceedings of the National Academy of Sciences
  17. Microglia dysfunction, neurovascular inflammation and focal neuropathologies are linked to IL-1- and IL-6-related systemic inflammation in COVID-19
    Rebeka Fekete, Alba Simats, Eduárd Bíró, Balázs Pósfai, Csaba Cserép, Anett D. Schwarcz, Eszter Szabadits, Zsuzsanna Környei, Krisztina Tóth, Erzsébet Fichó et al. · 2025 · Nature Neuroscience
  18. VISTA: A Target to Manage the Innate Cytokine Storm
    Mohamed A. ElTanbouly, Yanding Zhao, Evelien Schaafsma, Christopher M. Burns, Rodwell Mabaera, Chao Cheng, Randolph J. Noelle · 2021 · Frontiers in Immunology
  19. Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathology
    No‐Joon Song, Carter Allen, Anna E. Vilgelm, Brian Riesenberg, Kevin P. Weller, Kelsi Reynolds, Karthik B. Chakravarthy, Amrendra Kumar, Aastha Khatiwada, Zequn Sun et al. · 2022 · Journal of Hematology & Oncology
  20. Dysregulated Immune Responses in SARS-CoV-2-Infected Patients: A Comprehensive Overview
    Igor Vladimirovich Kudryavtsev, Artem Rubinstein, А. С. Головкин, Olga Kalinina, Kirill Vasilyev, Руденко Лариса Георгиевна, Исакова-Сивак Ирина Николаевна · 2022 · Viruses
  21. Toward an understanding of regulatory T cells in COVID‐19: A systematic review
    Mahsa Rahimzadeh, Nadereh Naderi · 2021 · Journal of Medical Virology
  22. Machine learning identifies T cell receptor repertoire signatures associated with COVID-19 severity
    Jonathan Joon-Young Park, Kyoung A. Viola Lee, Stanley Z. Lam, Katherine S. Moon, Zhenhao Fang, Sidi Chen · 2023 · Communications Biology
  23. Aging unconventionally: γδ T cells, iNKT cells, and MAIT cells in aging
    Ayako Kurioka, Paul Klenerman · 2023 · Seminars in Immunology
  24. Pediatric Inflammatory Multisystem Syndrome and Rheumatic Diseases During SARS-CoV-2 Pandemic
    Adrien Schvartz, Alexandre Bélot, Isabelle Koné‐Paut · 2020 · Frontiers in Pediatrics
  25. Validation of Inflammopathic, Adaptive, and Coagulopathic Sepsis Endotypes in Coronavirus Disease 2019
    Timothy E. Sweeney, Oliver Liesenfeld, James W. Wacker, Yudong D. He, David Rawling, Melissa Remmel, Sabrina Coyle, Uros Midic, Antigone Kotsaki, Aggeliki Kanavou et al. · 2020 · Critical Care Medicine
  26. Multisystem inflammatory syndrome in children during the COVID-19 pandemic in Turkey: first report from the Eastern Mediterranean
    Yasemin Özsürekçi, Sibel Laçinel Gürlevik, Selman Kesici, Ümmüşen Kaya Akça, Pembe Derin Oygar, Kübra Aykaç, Dilek Karacanoğlu, Özlem Sarıtaş Nakip, Sare İlbay, Banu Katlan et al. · 2021 · Clinical Rheumatology
  27. The contributory role of lymphocyte subsets, pathophysiology of lymphopenia and its implication as prognostic and therapeutic opportunity in COVID-19
    Mahda Delshad, Naeimeh Tavakolinia, Atieh Pourbagheri‐Sigaroodi, Ava Safaroghli‐Azar, Nader Bagheri, Davood Bashash · 2021 · International Immunopharmacology
  28. Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines
    Manish K. Dhawan, Ali Ahmed Rabaan, Mahmoud M. Fawarah, Souad A. Almuthree, Roua Abdullah Alsubki, Amal H. Alfaraj, Mutaib M. Mashraqi, Saleh Alshamrani, Wesam A. Abduljabbar, Ameen S. S. Alwashmi et al. · 2023 · Vaccines
  29. Opportunistic Fungal Infection Associated With COVID-19
    John M. Cafardi, Douglas Haas, Thomas Lamarre, Judith Feinberg · 2021 · Open Forum Infectious Diseases
  30. Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis
    Anne‐Gaëlle Goubet, Agathe Dubuisson, Arthur Géraud, F.X. Danlos, Safae Aarab Terrisse, Carolina Alves Costa Silva, Damien Drubay, Lea Touri, Marion Picard, Marine Mazzenga et al. · 2021 · Cell Death and Differentiation
  31. Long-term hypercoagulability, endotheliopathy and inflammation following acute SARS-CoV-2 infection
    Andrea Boccatonda, Elena Campello, Chiara Simion, Paolo Simioni · 2023 · Expert Review of Hematology
  32. Diagnostic Approaches For COVID-19: Lessons Learned and the Path Forward
    Maha Alafeef, Dipanjan Pan · 2022 · ACS Nano
  33. Preexisting and Post–COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer
    Tatjana Bilich, Malte Roerden, Yacine Maringer, Annika Nelde, Jonas S. Heitmann, Marissa Lisa Dubbelaar, Andreas Peter, Sebastian Hörber, Jens Bauer, Jonas Rieth et al. · 2021 · Cancer Discovery
  34. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort
    María J. Pons, Barbara Ymaña, Ana Mayanga-Herrera, Yolanda Sáenz, Lydia Alvarez‐Erviti, Salyoc Tapia-Rojas, Roxana Gamarra Ojeda, Amanda B. Blanco, Gemma Moncunill, Manuel Francisco Ugarte-Gil · 2021 · Frontiers in Immunology
  35. Severe respiratory viral infections: T-cell functions diverging from immunity to inflammation
    Joseph Yunis, Kirsty Renfree Short, Di Yu · 2023 · Trends in Microbiology
  36. Longitudinal assessment of IFN-I activity and immune profile in critically ill COVID-19 patients with acute respiratory distress syndrome
    the RICO study group, Fabienne Venet, Martin Cour, Thomas R. Rimmele, Sébastien Viel, Hodane Yonis, Rémy Coudereau, Camille Amaz, Paul Abraham, Céline Monard et al. · 2021 · Critical Care
  37. Spontaneous Breathing and Evolving Phenotypes of Lung Damage in Patients with COVID-19: Review of Current Evidence and Forecast of a New Scenario
    Roberto Tonelli, Alessandro Marchioni, Luca Tabbì, Riccardo Fantini, Stefano Busani, Ivana Castaniere, Dario Andrisani, Filippo Gozzi, Giulia Bruzzi, Linda Manicardi et al. · 2021 · Journal of Clinical Medicine
  38. High-Density Blood Transcriptomics Reveals Precision Immune Signatures of SARS-CoV-2 Infection in Hospitalized Individuals
    Jeremy W. Prokop, Nicholas Hartog, Dave W. Chesla, William Faber, Chanise P. Love, Rachid Karam, Nelly Abualkheir, Benjamin Feldmann, Li Teng, Tamara McBride et al. · 2021 · Frontiers in Immunology
  39. Sex-Related Differences in Innate and Adaptive Immune Responses to SARS-CoV-2
    Sudhanshu Agrawal, Jon V. Salazar, Thu Michelle Tran, Anshu Agrawal · 2021 · Frontiers in Immunology
  40. Prevalent and immunodominant CD8 T cell epitopes are conserved in SARS-CoV-2 variants
    Saskia Meyer, Isaac Blaas, Ravi Chand Bollineni, Marina Delić-Šarac, Trung The Tran, Cathrine F. Knetter, Ke‐Zheng Dai, Torfinn Støve Madssen, John Torgils Vaage, Alice Gustavsen et al. · 2023 · Cell Reports
  41. Mucosal-associated invariant T cell responses differ by sex in COVID-19
    Yu Chen, Sejiro Littleton, Nicholas S. Giroux, Rose Mathew, Shengli Ding, Joan Kalnitsky, Yuchen Yang, Elizabeth Petzold, Hong A. Chung, Grecia O. Rivera et al. · 2021 · Med
  42. Multiomics: unraveling the panoramic landscapes of SARS-CoV-2 infection
    Xin Wang, Gang Xu, Xiaoju Liu, Yang Liu, Shuye Zhang, Zheng Zhang · 2021 · Cellular and Molecular Immunology
  43. Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response
    Adrian Matthew Shields, Sian Elizabeth Faustini, Marisol Pérez-Toledo, Siân E. Jossi, Joel D. Allen, Saly Al‐Taei, Claire Backhouse, Lynsey Dunbar, Daniel Ebanks, Beena Emmanuel et al. · 2021 · BMJ Open Respiratory Research
  44. The kynurenine pathway of tryptophan metabolism: a neglected therapeutic target of COVID-19 pathophysiology and immunotherapy
    Abdulla A.‐B. Badawy · 2023 · Bioscience Reports
  45. Understanding the complexities of SARS-CoV2 infection and its immunology: A road to immune-based therapeutics
    Vijay Kumar · 2020 · International Immunopharmacology
  46. The Role of MSC Therapy in Attenuating the Damaging Effects of the Cytokine Storm Induced by COVID-19 on the Heart and Cardiovascular System
    Georgina M. Ellison, Liam Sean Colley, Katie A. O’Brien, Kirsty A. Roberts, Thomas A. Agbaedeng, Mark Ross · 2020 · Frontiers in Cardiovascular Medicine
  47. SARS-CoV-2 infection induces mixed M1/M2 phenotype in circulating monocytes and alterations in both dendritic cell and monocyte subsets
    Sanja D. Matic, Suzana Popović, Predrag M. Djurdjevic, Danijela Todorović, Nataša Djordjević, Željko Mijailović, Predrag S. Sazdanovic, Dragan R Milovanovic, Dejana Ružić Zečević, Marina D. Petrovic et al. · 2020 · PLoS ONE
  48. Natural killer cells and unconventional T cells in COVID-19
    Niklas K. Björkström, Andrea Ponzetta · 2021 · Current Opinion in Virology
  49. Comprehensive Immunologic Evaluation of Bronchoalveolar Lavage Samples from Human Patients with Moderate and Severe Seasonal Influenza and Severe COVID-19
    Daniel Reynolds, Cristina Vazquez Guillamet, Aaron Day, Nicholas C. Borcherding, Rodrigo Vazquez Guillamet, José Alberto Choreño-Parra, Stacey L. House, Jane A. O’Halloran, Joaquı́n Zúñiga, Ali H. Ellebedy et al. · 2021 · The Journal of Immunology
  50. Modeling recapitulates the heterogeneous outcomes of SARS-CoV-2 infection and quantifies the differences in the innate immune and CD8 T-cell responses between patients experiencing mild and severe symptoms
    Budhaditya Chatterjee, Harshbir Singh Sandhu, Narendra M. Dixit · 2022 · PLoS Pathogens
  51. Identifying common pharmacotherapies associated with reduced COVID-19 morbidity using electronic health records
    Victor Manuel Castro, Rachel Ross, Sean M. J. McBride, Roy H. Perlis · 2020 · medRxiv
  52. Plasma biomarker profiling of PIMS-TS, COVID-19 and SARS-CoV2 seropositive children – a cross-sectional observational study from southern India.
    Aishwarya Venkataraman, Nathella Pavan Kumar, Luke Elizabeth Hanna, Sulochana Putlibai, M. Sachin Karthick, Anuradha Rajamanikam, Kalaimaran Sadasivam, Balasubramanian Sundaram, Subash Babu · 2021 · EBioMedicine
  53. High CD4‐to‐CD8 ratio identifies an at‐risk population susceptible to lethal COVID‐19
    Marco De Zuani, Petra Lázničková, Veronika Tomášková, Martina Dvončová, Giancarlo Forte, Gorazd Bernard Stokin, Vladimír Šrámek, Martin Helán, Jan Frič · 2021 · Scandinavian Journal of Immunology
  54. An Inhaled Galectin-3 Inhibitor in COVID-19 Pneumonitis: A Phase Ib/IIa Randomized Controlled Clinical Trial (DEFINE)
    Erin E. Gaughan, Tom Michael Quinn, Andrew Mills, Annya M. Bruce, Jean Antonelli, Alison C. MacKinnon, Vassilios Aslanis, Feng Li, Richard A. O’Connor, Cecilia Boz et al. · 2022 · American Journal of Respiratory and Critical Care Medicine
  55. Heterogenous CD8+ T Cell Maturation and ‘Polarization’ in Acute and Convalescent COVID-19 Patients
    Igor Vladimirovich Kudryavtsev, Natalia A. Arsentieva, Zoia R. Korobova, Dmitry Isakov, Artem Rubinstein, Oleg K. Batsunov, I. V. Khamitova, Raisa N. Kuznetsova, Савин Тихон Валерьевич, Tatiana Akisheva et al. · 2022 · Viruses
  56. Protective reactive thymus hyperplasia in COVID-19 acute respiratory distress syndrome
    Pelagia Cuvelier, Hélène Roux, Anne Couëdel-Courteille, Jacques Dutrieux, Cécile Naudin, Bénédicte Charmeteau-De Muylder, Rémi Cheynier, Pierre Squara, Stéfano Marullo · 2021 · Critical Care
  57. Comparison of host endothelial, epithelial and inflammatory response in ICU patients with and without COVID-19: a prospective observational cohort study
    Pavan K. Bhatraju, Eric D. Morrell, Leila R. Zelnick, Neha Alhad Sathe, Xin-Ya Chai, Sana S. Sakr, Sharon K. Sahi, Anthony Sader, Dawn M. Lum, Ted Liu et al. · 2021 · Critical Care
  58. Protective immune trajectories in early viral containment of non-pneumonic SARS-CoV-2 infection
    Kami Pekayvaz, Alexander Leunig, Rainer W. J. Kaiser, Markus Joppich, Sophia Brambs, Aleksandar Janjic, Oliver Popp, Daniel Nixdorf, Valeria Fumagalli, Nora Schmidt et al. · 2022 · Nature Communications
  59. Synergism of TNF-α and IFN-γ triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes.
    Rajendra Karki, Bhesh Raj Sharma, Shraddha Tuladhar, Evan Peter Williams, Lillian Zalduondo, Parimal Samir, Min Zheng, Balamurugan Sundaram, Balaji Banoth, R. K. Subbarao Malireddi et al. · 2020 · PubMed
  60. High-dimensional single-cell analysis reveals the immune characteristics of COVID-19
    Wen Shi, Xiuxing Liu, Qiqi Cao, Pengjuan Ma, Wenqing Le, Lihui Xie, Jinguo Ye, Wen Wen, Hao Tang, Wenru Su et al. · 2020 · American Journal of Physiology-Lung Cellular and Molecular Physiology
  61. The COVID-19 immune landscape is dynamically and reversibly correlated with disease severity
    Hamid Bolouri, Cate Speake, David A. G. Skibinski, Sarah Alice Long, Anne M. Hocking, Daniel Campbell, Jessica A. Hamerman, Uma Malhotra, Jane Hoyt Buckner · 2021 · Journal of Clinical Investigation
  62. Myeloid-Derived Suppressor Cells as a Potential Biomarker and Therapeutic Target in COVID-19
    Marianna Rowlands, Florencia Segal, Dominik Hartl · 2021 · Frontiers in Immunology
  63. Human B-cell subset identification and changes in inflammatory diseases
    Rebekah L. Velounias, Thomas J Tull · 2022 · Clinical & Experimental Immunology
  64. Basophils beyond allergic and parasitic diseases
    Remo Poto, Stefania Loffredo, Gianni Marone, Antonio di Salvatore, Amato de Paulis, John T. Schroeder, Gilda Varricchi · 2023 · Frontiers in Immunology
  65. Immune recognition of phosphoantigen‐butyrophilin molecular complexes by γδ T cells
    Adam P. Uldrich, Marc Rigau, Dale Ian Godfrey · 2020 · Immunological Reviews
  66. How to Train Your Dragon: Harnessing Gamma Delta T Cells Antiviral Functions and Trained Immunity in a Pandemic Era
    Jonathan Caron, Laura A. Ridgley, Mark D. Bodman‐Smith · 2021 · Frontiers in Immunology
  67. Impact of SARS-CoV-2 on neuropsychiatric disorders
    María de los Ángeles Robinson‐Agramonte, Carlos‐Alberto Gonçalves, Elena Noris-García, Naybí Préndes Rivero, Anna Lisa Brigida, Stephen T. Schultz, Dario Siniscalco, Ramiro Jorge García García · 2021 · World Journal of Psychiatry
  68. Type I Interferon Induction and Exhaustion during Viral Infection: Plasmacytoid Dendritic Cells and Emerging COVID-19 Findings
    Trever T. Greene, Elina I. Zúñiga · 2021 · Viruses
  69. Human endogenous retrovirus K in the respiratory tract is associated with COVID-19 physiopathology
    Jairo Ramos Temerozo, Natalia Fintelman Rodrigues, Monique Cristina dos Santos, Eugênio Damaceno Hottz, Carolina Q. Sacramento, Aline de Paula Dias da Silva, Samuel Coelho Mandacaru, Emilly Caroline dos Santos Moraes, Monique R. O. Trugilho, João Silveira Moledo Gesto et al. · 2022 · Microbiome
  70. Single-cell RNA sequencing reveals immunological rewiring at the maternal-fetal interface following asymptomatic/mild SARS-CoV-2 infection
    Suhas Sureshchandra, Michael Z. Zulu, Brianna M. Doratt, Allen Jankeel, Delia F. Tifrea, Robert A. Edwards, Monica P. Rincon, Nicole Marshall, Ilhem Messaoudi · 2022 · Cell Reports
  71. Gastrointestinal involvement attenuates COVID-19 severity and mortality
    Alexandra E. Livanos, Divya Jha, Francesca Cossarini, Ana Silvia Gonzalez-Reiche, Minami A. Tokuyama, Teresa Aydillo, Tommaso Lorenzo Parigi, Irene Ramos, Katie A. Dunleavy, Brian Hyohyoung Lee et al. · 2020 · medRxiv
  72. The impact of ageing mechanisms on musculoskeletal system diseases in the elderly
    Yijin Cai, Zhongyu Han, Hong Cheng, Hongpeng Li, Ke Wang, Jia Chen, Zhixiang Liu, Yu‐Long Xie, Yumeng Lin, Shuwei Zhou et al. · 2024 · Frontiers in Immunology
  73. Innate Immunity in Protection and Pathogenesis During Coronavirus Infections and COVID-19
    R. K. Subbarao Malireddi, Bhesh Raj Sharma, Thirumala‐Devi Kanneganti · 2024 · Annual Review of Immunology
  74. Immune Responses to SARS-CoV-2 in Solid Organ Transplant Recipients
    Varun K. Phadke, Nicholas Scanlon, Stanley C. Jordan, Nadine Rouphael · 2021 · Current Transplantation Reports
  75. Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer
    Arielle Elkrief, Julie Tsu-Yu Wu, Chinmay Jani, Kyle T. Enriquez, Michael J. Glover, Mansi R. Shah, Hira Ghazal Shaikh, Alicia C. Beeghly-Fadiel, Benjamin C. French, Sachin R. Jhawar et al. · 2021 · Cancer Discovery
  76. SARS-CoV-2 infection results in immune responses in the respiratory tract and peripheral blood that suggest mechanisms of disease severity
    Wuji Zhang, Brendon Yew Loong Chua, Kevin John Selva, Łukasz Kedzierski, Thomas M. Ashhurst, Ebene R. Haycroft, Suzanne K. Shoffner, Luca Hensen, David F. Boyd, Fiona James et al. · 2022 · Nature Communications
  77. Multi-omics identify falling LRRC15 as a COVID-19 severity marker and persistent pro-thrombotic signals in convalescence
    Jack Gisby, Norzawani B Buang, Artemis Papadaki, Candice Clarke, Talat H. Malik, Nicholas Medjeral‐Thomas, Damiola Pinheiro, Paige M Mortimer, Shanice Lewis, Eleanor Sandhu et al. · 2022 · Nature Communications
  78. Immunometabolism of Tregs: mechanisms, adaptability, and therapeutic implications in diseases
    Yuming Lu, Yifan Wang, Tiantian Ruan, Yihan Wang, Linling Ju, Mengya Zhou, Luyin Liu, Yao Dengfu, Min Yao · 2025 · Frontiers in Immunology
  79. Role of Multiomics Data to Understand Host–Pathogen Interactions in COVID-19 Pathogenesis
    Shalini Aggarwal, Arup Acharjee, Amrita Mukherjee, Mark S. Baker, Sanjeeva Srivastava · 2021 · Journal of Proteome Research
  80. COVID‐19 plasma proteome reveals novel temporal and cell‐specific signatures for disease severity and high‐precision disease management
    Cristiana Iosef, Claudio M. Martin, Marat Slessarev, Carolina Gillio‐Meina, Gediminas Cepinskas, Victor K. M. Han, Douglas D. Fraser · 2022 · Journal of Cellular and Molecular Medicine
  81. CXCR3-Expressing T Cells in Infections and Autoimmunity
    Artem Rubinstein, I. V. Kudryavtsev, Natalia A. Arsentieva, Zoia R. Korobova, Dmitry Isakov, Арег А. Тотолян · 2024 · Frontiers in Bioscience-Landmark
  82. Tracking the clonal dynamics of SARS-CoV-2-specific T cells in children and adults with mild/asymptomatic COVID-19
    Weng Hua Khoo, Katherine Jackson, Chansavath Phetsouphanh, John Zaunders, José Alquicira-Hernández, Seyhan Yazar, Stephanie Ruiz‐Diaz, Mandeep Singh, Rama Dhenni, Wunna Kyaw et al. · 2022 · Clinical Immunology
  83. Lower respiratory tract single-cell RNA sequencing and neutrophil extracellular trap profiling of COVID-19-associated pulmonary aspergillosis: a single centre, retrospective, observational study
    Simon Feys, Sam Vanmassenhove, Sirima Kraisin, Karen Yu, Cato Jacobs, Bram Boeckx, Seppe Cambier, Cristina Cunha, Yves A. Debaveye, Samuel Martins Gonçalves et al. · 2024 · The Lancet Microbe
  84. Maturation signatures of conventional dendritic cell subtypes in COVID‐19 suggest direct viral sensing
    Laura Marongiu, Giulia Protti, Fabio Alessandro Facchini, Mihai Valache, Francesca Mingozzi, Valeria Ranzani, Anna Rita Putignano, Lorenzo Salviati, Valeria Bevilacqua, Serena Curti et al. · 2021 · European Journal of Immunology
  85. Binding of phosphatidylserine‐positive microparticles by PBMCs classifies disease severity in COVID‐19 patients
    Lisa Rausch, Konstantin Lutz, Martina Schifferer, Elena Winheim, Rudi Gruber, Elina F. Oesterhaus, Linus Rinke, Johannes C. Hellmuth, Clemens Scherer, Maximilian Muenchhoff et al. · 2021 · Journal of Extracellular Vesicles
  86. Plasmacytoid dendritic cells during COVID-19: Ally or adversary?
    Renée Marije van der Sluis, Christian Kanstrup Holm, Martin R. Jakobsen · 2022 · Cell Reports
  87. The impact of the self-recognition ability and physical quality on coupled negative information-behavior-epidemic dynamics in multiplex networks
    Liang’an Huo, Yue Yu · 2023 · Chaos Solitons & Fractals
  88. Comparative immune profiling of acute respiratory distress syndrome patients with or without SARS-CoV-2 infection
    Mikaël Roussel, Juliette Ferrant, Florian Reizine, Simon Le Gallou, Joëlle Dulong, Sarah H. Carl, Matheiu Lesouhaitier, Murielle Grégoire, Nadège Bescher, Clotilde Verdy et al. · 2021 · Cell Reports Medicine
  89. Rapid and sustained decline in CXCL-10 (IP-10) annotates clinical outcomes following TNFα-antagonist therapy in hospitalized patients with severe and critical COVID-19 respiratory failure
    Hilal Hachem, Amandeep Godara, Courtney Schroeder, Daniel E.C. Fein, Hashim Mann, Christian Lawlor, Jill Marshall, Andreas K. Klein, Debra D. Poutsiaka, Janis L. Breeze et al. · 2021 · Journal of Clinical and Translational Science
  90. Genetic and phenotypic analysis of the causal relationship between aging and COVID-19
    Kejun Ying, Ranran Zhai, Timothy V. Pyrkov, Anastasia V. Shindyapina, Marco Mariotti, Peter O. Fedichev, Xia Shen, Vadim N. Gladyshev · 2021 · Communications Medicine
  91. Metformin Suppresses Monocyte Immunometabolic Activation by SARS-CoV-2 Spike Protein Subunit 1
    T. Cory, R. Emmons, Johnathan R. Yarbro, Kierstin L. Davis, Brandt D. Pence · 2021 · Frontiers in Immunology
  92. Antiviral therapy for COVID-19: Derivation of optimal strategy based on past antiviral and favipiravir experiences
    Kimiyasu Shiraki, Noriaki Sato, Kaoru Sakai, Shirou Matsumoto, Richard H. Kaszynski, Masaya Takemoto · 2022 · Pharmacology & Therapeutics
  93. The role of dendritic cells in COVID-19 infection
    Xuying Wang, Fei Guan, H. I. Miller, Maria G. Byazrova, Fabio Candotti, Kamel Benlagha, Niels Olsen Saraiva Câmara, Jiahui Lei, Alexander V. Filatov, Chaohong Liu · 2023 · Emerging Microbes & Infections
  94. Future applications of host direct therapies for infectious disease treatment
    Ruth E. Thom, Riccardo V. D’Elia · 2024 · Frontiers in Immunology
  95. Peripheral Blood Immune Profiling of Convalescent Plasma Donors Reveals Alterations in Specific Immune Subpopulations Even at 2 Months Post SARS-CoV-2 Infection
    Nikolaos Orologas‐Stavrou, Marianna Politou, Pantelis Rousakis, Ioannis V. Kostopoulos, Ioannis Ntanasis‐Stathopoulos, Edison Jahaj, Eleni Tsiligkeridou, Maria Gavriatopoulou, Efstathios Kastritis, Αnastasia Kotanidou et al. · 2020 · Viruses
  96. Plasma cytokines in patients with COVID-19 during acute phase of the disease and following complete recovery
    Natalia A. Arsentieva, Natalia E. Liubimova, Oleg K. Batsunov, Zoia R. Korobova, Oksana V. Stanevich, Aleksandra A. Lebedeva, Evgeny A. Vorobyov, Snezhana V. Vorobyeva, А. Н. Куликов, Dmitry A. Lioznov et al. · 2021 · Medical Immunology (Russia)
  97. A dynamic mucin mRNA signature associates with COVID-19 disease presentation and severity
    Annemieke Smet, Tom Breugelmans, Johan Míchiels, Kevin Lamote, Wout Arras, Joris G. De Man, Leo Heyndríckx, Anne Hauner, Manon Thirza Huizing, Surbhi Malhotra‐Kumar et al. · 2021 · JCI Insight
  98. Therapeutic potential of melatonin and melatonergic drugs on K18‐hACE2 mice infected with SARS‐CoV‐2
    Erika Cecon, Charlotte Izabelle, Sophie Le Poder, Fernando Real, Aiwei Zhu, Ly Tu, Maria‐Rosa Ghigna, Bernard Klonjkowski, Morgane Bomsel, Ralf Jockers et al. · 2021 · Journal of Pineal Research
  99. Heterologous ChAdOx1-BNT162b2 vaccination in Korean cohort induces robust immune and antibody responses that includes Omicron
    Hye‐Kyung Lee, Jinyoung Go, Heungsup Sung, Seong Who Kim, Mary F. Walter, Ludwig Knabl, Priscilla A. Furth, Lothar G. Hennighausen, Jin Won Huh · 2022 · iScience
  100. Pattern-recognition receptors (PRRs) in SARS-CoV-2
    Alireza Isazadeh, Javad Ahmadian Heris, Parviz Shahabi, Reza Mohammadinasab, Navid Shomali, Hadi Nasiri, Zahra Valedkarimi, Ahmad Jamei Khosroshahi, Saba Hajazimian, Morteza Akbari et al. · 2023 · Life Sciences